HomeGeneticsGenePOFUT1 gene
Back to Gene
POFUT1 gene
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Gene

POFUT1 gene

The POFUT1 gene encodes a protein that modifies Notch receptors with sugar molecules, a process vital for cell signaling and tissue development.

Normal Function

The POFUT1 gene provides instructions for making a protein called protein O-fucosyltransferase 1. Located in the endoplasmic reticulum, this protein adds sugar molecules called fucose to Notch receptors. These receptors are part of a signaling pathway that guides the development of many tissues throughout the body.

The addition of fucose alters the shape of the Notch receptor, enabling it to bind to its ligand and trigger signaling. This pathway is essential for:

  • Cell fate determination: Specializing cells for specific functions.
  • Proliferation: Cell growth and division.
  • Differentiation: Cell maturation.
  • Apoptosis: Programmed cell self-destruction.

In skin cells, Notch signaling is thought to maintain precursor cells that mature into melanocytes and may regulate the interactions between melanocytes and keratinocytes.

Health Conditions Related to Genetic Changes

Dowling-Degos disease

At least 13 mutations in the POFUT1 gene have been linked to Dowling-Degos disease. This condition causes skin abnormalities, most notably a lacy pattern of dark skin coloring (hyperpigmentation) in the body's folds and creases.

Mutations in this gene result in a partial or total loss of protein function. Without the addition of fucose, Notch receptors cannot bind to their ligands, halting the Notch pathway. It is currently unclear whether the symptoms of Dowling-Degos disease result from this impaired signaling or from the disruption of other, unknown functions of protein O-fucosyltransferase 1 in skin cells.

Frequently Asked Questions

Testing is done via a blood sample sent to a genetics laboratory. The lab performs targeted sequencing of the POFUT1 gene or includes it in a broader skin‑disease panel. The process takes about 4–6 weeks, and results are interpreted by a clinical geneticist.
POFUT1 encodes an enzyme that fucosylates Notch receptors. Mutations that reduce or eliminate this activity prevent proper Notch signaling in skin cells, leading to abnormal melanocyte behavior and the distinctive lacy dark patches seen in Dowling‑Degos disease.
No approved targeted therapies exist yet. Some patients are enrolled in early‑phase trials exploring Notch‑modulating drugs or gene‑editing approaches, but these are experimental and not widely available. Patients should discuss trial options with a dermatologist or geneticist.
Yes. Daily broad‑spectrum sunscreen, gentle skin cleansers, and topical agents such as azelaic acid, niacinamide, or low‑dose retinoids can reduce hyperpigmentation. Avoiding harsh chemicals and extreme temperatures also helps maintain skin integrity. Regular follow‑up with a dermatologist is recommended to adjust treatment.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

Meyahealth

Ⓒ 2026. All rights reserved by MEYA